Skip to main content
. 2018 Nov 19;53(Suppl 1):145–805. doi: 10.1038/s41409-018-0354-7
Local group N (%) Foreign group N (%) P value
induction at AUBMC/ referred for transplant 44 (43) / 59 (57) 19 (33) / 39 (67) NS/NS
Referred from Iraqi/ Syrian/ UAE/jordanian NA 46(79) / 8(14)/ 3 (5) / 1(2) NS/NS/NS
Disease: AML / ALL/ NHL/HL/aplastic anemia/others 48(47) / 16(16)/10(10)/16(16)/5(5)/8(8) 31(53) / 13 (22)/3 (5)/ 1(2) / 6 (10)/ 4 (7) NS/NS/NS/0.006/NS/NS
Type of donor MRD/Haplo/MUD 76 (74)/ 22(21)/5(5) 55 (95)/2(3)/1 (2) 0.0007/ 0.0022/NS
DRI Low / intermediate/high 6 (6) / 59(57) / 31 (30) 5 (8) / 27(46) / 20 (34) NS/NS/NS
Status At transplant: CR/ CR1/ CR2/ CR3/ 68(66) 39(57) 18(26) 11(16) 34(59)/ 20(59)/ 8(23)/ 6(18)/ NS / NS/ NS/ NS /
Stable disease-Partial Response/progression relapse 18 (17)/17 (17) 10 (17)/14(24) NS
Conditioning Regimen TBF-ATG / FB-ATG / FB-ATG-TBI / Sequential / Others 21 (20) / 39 (38) / 5 (5) / 8 (8) / 30 (29) 4 (7) / 30 (52) / 2 (3) / 3 (5) / 19 (33) / 0.038 / NS / NS / NS / NS /NS
Last Follow up Complete remission/ Relapse-Progression/ lost to follow up 71 (69) / 32 (31)/ 0(0) 34 (58)/ 12 (21) / 12 (21) NS/NS